Revance Therapeutics | 4:持股变动声明-高管 Jordan Erica
04/18 04:40
Revance Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-JPMORGAN CHASE & CO.(2.6%)
04/10 01:20
Revance Therapeutics | DEFA14A:其他
03/22 04:13
Revance Therapeutics | DEF 14A:股东委托书决议
03/22 04:12
Revance Therapeutics | 4:持股变动声明-高管 Sjuts Dustin S
03/20 06:48
Revance Therapeutics | 4:持股变动声明-高管 Moxie Dwight
03/20 06:48
Revance Therapeutics | 4:持股变动声明-高管 Schilke Tobin
03/20 06:48
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
03/20 06:47
Revance Therapeutics | 144:拟议出售证券
03/18 18:19
Revance Therapeutics | 144:拟议出售证券
03/18 18:14
Revance Therapeutics | 144:拟议出售证券
03/18 18:14
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
03/09 05:38
Revance Therapeutics | 8-K:重大事件
03/06 06:09
Revance Therapeutics | 424B5:募资说明书
03/06 06:07
Revance Therapeutics | 4:持股变动声明-高管 Sjuts Dustin S
03/05 06:41
Revance Therapeutics | 4:持股变动声明-高管 Moxie Dwight
03/05 06:40
Revance Therapeutics | 4:持股变动声明-高管 Schilke Tobin
03/05 05:46
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
03/05 05:37
Revance Therapeutics | 424B5:募资说明书
03/04 19:44
Revance Therapeutics | 3:首次持股声明-高管 Jordan Erica
03/01 05:44
暂无数据
暂无数据